"At GenesisCare, we offer multidisciplinary personalised cancer treatments based on the needs of our patients as individuals.We’re an organisation with a local, national and global presence, providing care where it’s needed. Our radiation and medical oncologists are among the world’s leading specialists in the treatment of cancer. We invest in innovative treatments, advanced technologies and clinical trials with the goal to continually improve patient outcomes. Our services include rapid diagnostic pathways, radiation oncology, medical oncology and theranostics."

During the past decade, GenesisCare Oxford conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GenesisCare Oxford" are "Chronic Lymphocytic Leukemia" (1 trials), "Relapsed and/or Refractory Multiple Myeloma" (1 trials) and "Small Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "GenesisCare Oxford" in a lesser frequency.

Most popular intervention types in "GenesisCare Oxford" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (1 trials), "Ibrutinib" (1 trials), "Ixazomib" (1 trials), "Pomalidomide" (1 trials) and "Zanubrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare Oxford" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GenesisCare Oxford". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GenesisCare Oxford, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare Oxford, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".